Stonebridge Capital Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-5,244
| Closed | -$1.84M | – | 217 |
|
|
2025
Q4 | $1.84M | Sell |
5,244
-195
| -4% | -$65.9K | 0.13% | 92 |
|
|
2025
Q3 | $1.76M | Sell |
5,439
-98
| -2% | -$30.5K | 0.13% | 92 |
|
|
2025
Q2 | $2.15M | Buy |
5,537
+933
| +20% | +$375K | 0.16% | 84 |
|
|
2025
Q1 | $2M | Buy |
4,604
+159
| +4% | +$63.8K | 0.16% | 83 |
|
|
2024
Q4 | $1.64M | Sell |
4,445
-176
| -4% | -$73.6K | 0.13% | 94 |
|
|
2024
Q3 | $2.4M | Sell |
4,621
-61
| -1% | -$32.6K | 0.2% | 84 |
|
|
2024
Q2 | $2.54M | Sell |
4,682
-663
| -12% | -$350K | 0.22% | 78 |
|
|
2024
Q1 | $2.77M | Buy |
5,345
+124
| +2% | +$61.7K | 0.25% | 78 |
|
|
2023
Q4 | $2.46M | Buy |
5,221
+130
| +3% | +$60.1K | 0.25% | 80 |
|
|
2023
Q3 | $2.22M | Sell |
5,091
-50
| -1% | -$22.7K | 0.24% | 83 |
|
|
2023
Q2 | $2.28M | Sell |
5,141
-335
| -6% | -$155K | 0.24% | 84 |
|
|
2023
Q1 | $2.52M | Buy |
5,476
+50
| +0.9% | +$23.8K | 0.29% | 77 |
|
|
2022
Q4 | $2.78M | Buy |
5,426
+32
| +0.6% | +$16.2K | 0.33% | 73 |
|
|
2022
Q3 | $2.45M | Buy |
5,394
+97
| +2% | +$46.4K | 0.32% | 77 |
|
|
2022
Q2 | $2.56M | Sell |
5,297
-88
| -2% | -$43.5K | 0.31% | 80 |
|
|
2022
Q1 | $2.65M | Sell |
5,385
-5
| -0.1% | -$2.29K | 0.29% | 84 |
|
|
2021
Q4 | $2.5M | Buy |
5,390
+132
| +3% | +$55.5K | 0.28% | 86 |
|
|
2021
Q3 | $1.96M | Sell |
5,258
-265
| -5% | -$101K | 0.24% | 95 |
|
|
2021
Q2 | $2.11M | Buy |
5,523
+65
| +1% | +$24.8K | 0.26% | 97 |
|
|
2021
Q1 | $1.96M | Sell |
5,458
-95
| -2% | -$30.6K | 0.26% | 94 |
|
|
2020
Q4 | $1.78M | Sell |
5,553
-422
| -7% | -$130K | 0.27% | 93 |
|
|
2020
Q3 | $1.6M | Sell |
5,975
-130
| -2% | -$35K | 0.29% | 83 |
|
|
2020
Q2 | $1.6M | Buy |
6,105
+20
| +0.3% | +$5.34K | 0.3% | 87 |
|
|
2020
Q1 | $1.38M | Sell |
6,085
-335
| -5% | -$91.3K | 0.29% | 86 |
|
|
2019
Q4 | $1.94M | Buy |
6,420
+315
| +5% | +$86.7K | 0.32% | 85 |
|
|
2019
Q3 | $1.47M | Buy |
6,105
+480
| +9% | +$132K | 0.25% | 92 |
|
|
2019
Q2 | $1.59M | Sell |
5,625
-235
| -4% | -$64.2K | 0.28% | 88 |
|
|
2019
Q1 | $1.68M | Sell |
5,860
-5,335
| -48% | -$1.54M | 0.31% | 87 |
|
|
2018
Q4 | $2.94M | Sell |
11,195
-1,380
| -11% | -$379K | 0.69% | 53 |
|
|
2018
Q3 | $3.45M | Sell |
12,575
-230
| -2% | -$59.7K | 0.69% | 54 |
|
|
2018
Q2 | $3.05M | Buy |
12,805
+565
| +5% | +$131K | 0.66% | 57 |
|
|
2018
Q1 | $2.69M | Sell |
12,240
-640
| -5% | -$150K | 0.62% | 61 |
|
|
2017
Q4 | $2.9M | Sell |
12,880
-851
| -6% | -$181K | 0.66% | 59 |
|
|
2017
Q3 | $2.61M | Sell |
13,731
-869
| -6% | -$165K | 0.64% | 58 |
|
|
2017
Q2 | $2.75M | Sell |
14,600
-520
| -3% | -$93.4K | 0.72% | 56 |
|
|
2017
Q1 | $2.5M | Sell |
15,120
-732
| -5% | -$116K | 0.68% | 56 |
|
|
2016
Q4 | $2.28M | Sell |
15,852
-938
| -6% | -$126K | 0.68% | 56 |
|
|
2016
Q3 | $2.1M | Sell |
16,790
-240
| -1% | -$31K | 0.66% | 55 |
|
|
2016
Q2 | $2.24M | Buy |
17,030
+300
| +2% | +$41K | 0.76% | 49 |
|
|
2016
Q1 | $2.33M | Sell |
16,730
-225
| -1% | -$30.1K | 0.82% | 45 |
|
|
2015
Q4 | $2.36M | Sell |
16,955
-145
| -0.8% | -$20K | 0.86% | 42 |
|
|
2015
Q3 | $2.39M | Buy |
+17,100
| New | +$2.57M | 0.96% | 36 |
|
Other funds holding ELV
Stonebridge Capital Advisors's ELV Position: Q1 2026 in Review
Stonebridge Capital Advisors sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 5,244 shares — an estimated $1.84M sold.
Stonebridge Capital Advisors first reported a position in ELV in Q3 2015 and held it in 42 quarters. The position peaked at $3.45M in Q3 2018. 1,469 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Stonebridge Capital Advisors reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
- Stonebridge Capital Advisors sold 5,244 Elevance Health shares in Q1 2026, an estimated $1.84M.
- Stonebridge Capital Advisors first reported a position in Elevance Health in Q3 2015 and held it in 42 quarters.
- Stonebridge Capital Advisors's Elevance Health position peaked at $3.45M in Q3 2018.
- 1,469 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Stonebridge Capital Advisors's 13F filing for Q1 2026, filed 14 May 2026.